Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SANTHERA PHARMACEUTICALS HOLDING AG

(SANN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Santhera Secures CHF 45 Million in Funding and Announces Preliminary First Half-Year 2021 Financial Results

09/20/2021 | 01:00am EDT

(MORE TO FOLLOW) Dow Jones Newswires

September 20, 2021 01:00 ET (05:00 GMT)

All news about SANTHERA PHARMACEUTICALS HOLDING AG
10/15PRESS RELEASE : Santhera Announces First Half-Year -3-
DJ
10/15PRESS RELEASE : Santhera Announces First Half-Year -2-
DJ
10/15PRESS RELEASE : Santhera Announces First Half-Year 2021 Financial Results and Updates on C..
DJ
10/15Santhera Announces First Half-Year 2021 Financial Results and Updates on Corporate Prog..
DJ
10/13SANTHERA PHARMACEUTICALS : 2021 Santhera Interim Report
PU
10/01PRESS RELEASE : Santhera will Publish its Interim Report for the First Half of 2021 on Oct..
DJ
10/01Santhera will Publish its Interim Report for the First Half of 2021 on October 15, 2021
DJ
09/27SANTHERA PHARMACEUTICALS : ReveraGen Get US FDA Orphan Grant to Study Vamorolone in Becker..
MT
09/27SANTHERA PHARMACEUTICALS : Issues Remaining Shares in $22 Million Private Placement
MT
09/27PRESS RELEASE : ReveraGen and Santhera Announce FDA Orphan Grant Funding for Clinical Tria..
DJ
More news
Financials
Sales 2021 16,8 M 18,1 M 18,1 M
Net income 2021 -38,1 M -41,2 M -41,2 M
Net cash 2021 1,00 M 1,08 M 1,08 M
P/E ratio 2021 -1,46x
Yield 2021 -
Capitalization 58,8 M 63,6 M 63,6 M
EV / Sales 2021 3,45x
EV / Sales 2022 0,74x
Nbr of Employees 86
Free-Float 82,0%
Chart SANTHERA PHARMACEUTICALS HOLDING AG
Duration : Period :
Santhera Pharmaceuticals Holding AG Technical Analysis Chart | SANN | CH0027148649 | MarketScreener
Technical analysis trends SANTHERA PHARMACEUTICALS HOLDING AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 1,40 CHF
Average target price 6,40 CHF
Spread / Average Target 357%
EPS Revisions
Managers and Directors
Dario Eklund Chief Executive Officer
Andrew P. Smith Chief Financial Officer
Elmar J. Schnee Chairman
Martin Gertsch Vice Chairman
Philipp Gutzwiller Independent Director